Placental Mitochondrial Function and Dysfunction in Preeclampsia
International Journal of Molecular Sciences · 20.02.2023 · 24 (4) · 4177
DOI: 10.3390/ijms24044177 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.02.2023. Verfasst von Fahmida Jahan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension, Placenta Diseases. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The placenta is a vital organ of pregnancy, regulating adaptation to pregnancy, gestational parent/fetal exchange, and ultimately, fetal development and growth. Not surprisingly, in cases of placental dysfunction—where aspects of placental development or function become compromised—adverse pregnancy outcomes can result. One common placenta-mediated disorder of pregnancy is preeclampsia (PE), a hypertensive disorder of pregnancy with a highly heterogeneous clinical presentation. The wide array of clinical characteristics observed in pregnant individuals and neonates of a PE pregnancy are likely the result of distinct forms of placental pathology underlying the PE diagnosis, explaining why no one common intervention has proven effective in the prevention or treatment of PE. The historical paradigm of placental pathology in PE highlights an important role for utero–placental malperfusion, placental hypoxia and oxidative stress, and a critical role for placental mitochondrial dysfunction in the pathogenesis and progression of the disease. In the current review, the evidence of placental mitochondrial dysfunction in the context of PE will be summarized, highlighting how altered mitochondrial function may be a common feature across distinct PE subtypes. Further, advances in this field of study and therapeutic targeting of mitochondria as a promising intervention for PE will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
ORCID-Profile: Goutham Vasam, Alex E Green, Shannon A Bainbridge, Keir J Menzies
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Jahan, F., Vasam, G., Green, A. E., Bainbridge, S. A., & Menzies, K. J. (2023). Placental Mitochondrial Function and Dysfunction in Preeclampsia. International Journal of Molecular Sciences, 24(4), 4177. https://doi.org/10.3390/ijms24044177
Vancouver
Jahan F, Vasam G, Green AE, Bainbridge SA, Menzies KJ. Placental Mitochondrial Function and Dysfunction in Preeclampsia. International Journal of Molecular Sciences. 2023;24(4):4177. doi:10.3390/ijms24044177
BibTeX
@article{Jahan2023,
author = {Jahan, Fahmida and Vasam, Goutham and Green, Alex E and Bainbridge, Shannon A and Menzies, Keir J},
title = {Placental Mitochondrial Function and Dysfunction in Preeclampsia},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4177},
doi = {10.3390/ijms24044177}
}
EUVIMED